secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTERPACE BIOSCIENCES, INC. (IDXG)
CIK:        0001054102
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001493152-21-027037
Event type: debt
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Interpace enters $8M term loan with BroadOak at 9% to repay private equity loans
--------------------------------------------------------------------------------

- $8M term loan from BroadOak at 9% interest, matures Oct 2024 or change-of-control.
- Proceeds used to repay $4.5M Ampersand and $3M 1315 Capital promissory notes plus interest.
- Loan includes 3% origination fee and terminal payment of 15%-30% of original principal.
- Subordinate to Comerica's $7.5M revolving facility; secured by substantially all assets.
- Company believes new debt improves liquidity and operating flexibility without dilution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1054102/000149315221027037/0001493152-21-027037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1054102/000149315221027037/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-027037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer